Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia

Circulation

Volumn 96, Issue 2, 1997, Pages 526-534

  Anker, Stefan D ^a,b   Chua, Tuan Peng ^a   Ponikowski, Piotr ^a   Harrington, Derek ^a   Swan, Jon W ^a   Kox, Wolfgang J ^c   Poole Wilson, Philip A ^a   Coats, Andrew J S ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c NONE

Author keywords

Cachexia; Catecholamines; Heart failure; Hormones; Metabolism

Indexed keywords

ADRENALIN; CYTOKINE; ESTROGEN; HORMONE; HUMAN GROWTH HORMONE; HYDROCORTISONE; INSULIN; NORADRENALIN; PRASTERONE; SODIUM; SOMATOMEDIN C; TESTOSTERONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; CACHEXIA; CATABOLISM; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE SEVERITY; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE OXYGEN CONSUMPTION; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE ATROPHY; PRIORITY JOURNAL; SODIUM BLOOD LEVEL; WEIGHT REDUCTION;

EID: 0342460492     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.2.526     Document Type: Article

References (35)

1. Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol. 1992;20:248-254.
2. Abel RM, Fischer J, Buckley MJ, Barnett GO, Austen WG. Malnutrition in cardiac surgical patients. Arch Surg. 1976;111:45-50.
3. Katz AM, Katz PB. Diseases of heart in works of Hippocrates. Br Heart J. 1962;24:257-264.
4. Pittman JG, Cohen P. The pathogenesis of cardiac cachexia. N Engl J Med. 1964;271:403-409.
5. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990;323:236-241.
6. McMurray J, Abdullah I, Dargie HJ, Shapiro D. Increased concentrations of tumor necrosis factor in 'cachectic' patients with severe chronic heart failure. Br Heart J. 1991;66:356-358.
7. Dutka DP, Elborn JS, Delamere F, Shale DJ, Morris GK. Tumor necrosis factor a in severe congestive cardiac failure. Br Heart J. 1993;70:141-143.
8. Tracey KJ, Morgello S, Koplin B, Fahey TJ III, Fox J, Aledo A, Manogue KR, Cerami A. Metabolic effects of cachectin/tumor necrosis factor are modified by site of production: cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia. J Clin Invest. 1990;86:2014-2024.
9. Himms-Hagen J. Thyroid hormones and thermogenesis. In: Girardier L, Stock MJ, eds. Mammalian Thermogenesis. London, UK: Chapman & Hall; 1983:141-177.
10. Poehlman ET, Danforth E. Endurance training increases metabolic rate and norepinephrine appearance rate in older individuals. Am J Physiol. 1991;261:E233-E239.
11. Poehlmann ET, Scheffers J, Gottlieb SS, Fisher ML, Vaitekevicius P. Increased resting metabolic rate in patients with congestive heart failure. Ann Intern Med. 1994;121:860-862.
12. Anand IS, Ferrari R, Kalra GS, Wahi PL, Poole-Wilson PA, Harris PC. Edema of cardiac origin: studies on body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure. Circulation. 1989;80:299-305.
13. Swan JW, Walton C, Godsland IF, Clark AL, Coats AJS, Oliver MF. Insulin resistance in chronic heart failure. Eur Heart J. 1994; 15:1528-1532.
14. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector TS. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984;311:819-823.
15. Swedberg K, Eneroth P, Kjekshus J, Wilhelmsen L, for the CONSENSUS Trial Study Group. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. Circulation. 1990;82:1730-1736.
16. Francis GS, Cohn JN, Johnson G, Rector TS, Goldman S, Simon A, for the V-HeFT VA Cooperative Studies Group. Plasma norepinephrine, plasma renin activity, and congestive heart failure: relations to survival and the effects of therapy in V-HeFT II. Circulation. 1993;87(suppl VI):VI-40-VI-48.
17. Volterrani M, Clark AL, Ludman PF, Swan JW, Adamopopoulos S, Piepoli M, Coats AJS. Predictors of exercise capacity in chronic heart failure. Eur Heart J. 1994;15:801-809.
18. Engelberts I, Stephens S, Francot GJM, Van der Linden CJ, Buurman WA. Evidence for different effects of soluble TNF-receptors on various TNF measurements in human biological fluids. Lancet. 1991;338:515-516.
19. National Center for Health Statistics. Weight by height and age for adults 18-74 years: United States 1971-1974. Vital and health statistics. Series 11. No. 208. Washington DC: Government Printing Office; 1979. DHEW publication PHS 79-1656.
20. Carr JG, Stevenson LW, Walden JA, Heber D. Prevalence and hemodynamic correlates of malnutrition in severe congestive heart failure secondary to ischemic or ideopathic dilated cardiomyopathy. Am J Cardiol. 1989;63:709-713.
21. Otaki M. Surgical treatment of patients with cardiac cachexia: an analysis of factors affecting operative mortality. Chest. 1994;105: 1347-1351.
22. Buchanan N, Keen RD, Kingsley R, Eyberg CD. Gastrointestinal absorption studies in cardiac cachexia. Intensive Care Med. 1977;3: 89-91.
23. Thomas RD, Silverton NP, Burkinshaw L, Morgan DB. Potassium depletion and tissue loss in chronic heart disease. Lancet. 1979; 310:9-11.
24. Mancini DM, Walter G, Reichek N, Lenkinski R, McCully KK, Mullen JL, Wilson JR. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation. 1992;85:1364-1373.
25. Vescovo G, Serafini F, Facchin L, Tenderini P, Carraro U, Della Libera L, Catani C, Ambrosio GB. Specific changes in skeletal muscle myosin heavy chains composition in cardiac failure: differences compared with disuse atrophy as assessed on microbiopsies by high resolution electrophoresis. Heart. 1996;76: 337-343.
26. Simioni A, Long CS, Yue P, Dudley GA, Massie BM. Heart failure in rats causes changes in skeletal muscle phenotype and gene expression unrelated to locomotor activity. Circulation. 1995; 92(suppl I):I-259. Abstract.
27. Cohn AE, Steele JM. Unexplained fever in heart failure. J Clin Invest. 1934;13:853-868.
28. Torre-Amione G, Kapadia S, Lee J, Durand J-B, Bies RD, Young JB, Mann DL. Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart. Circulation. 1996;93:704-711.
29. Goldstein DS. Plasma norepinephrine as an indicator of sympathetic neural activity in clinical cardiology. Am J Cardiol. 1981;48: 1147-1154.
30. Landsberg L, Young JB. Catecholamines and the adrenal medulla. In: Wilson JD, Foster DW, eds. Williams Textbook of Endocrinology. Philadelphia, Pa: WB Saunders; 1992:621-705.
31. Chidsey CA, Harrison DC, Braunwald E. The augmentation of plasma norepinephrine response to exercise in patients with congestive heart failure. N Engl J Med. 1962;267:650-654.
32. Orth DN, Kovacs WJ, DeBold CR. The adrenal cortex. In: Wilson JD, Foster DW, ed. Williams Textbook of Endocrinology. Philadelphia, Pa: WB Saunders; 1992:489-619.
33. Nicholls MG, Espiner EA, Donald RA, Hughes H. Aldosterone and its regulation during diuresis in patients with gross congestive heart failure. Clin Sci Mol Med. 1974;47:301-315.
34. Underwood LE, Van Wyk JJ. Normal and aberrant growth. In: Wilson JD, Foster DW, ed. Williams Textbook of Endocrinology. Philadelphia, Pa: WB Saunders; 1992:1079-1138.
35. Xiong Y, Hales DB. The role of tumor necrosis factor-α in the regulation of mouse Leydig cell steroidgenesis. Endocrinology. 1993;132:2438-2444.